Vaishali Pharma Ltd.Vaishali Pharma Ltd.Vaishali Pharma Ltd.

Vaishali Pharma Ltd.

No trades
No trades

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, Q4 FY2026
May 30, 2026
Strong revenue and profit growth, with new associate consolidation and auditor caution on receivables.
Earnings, Q3 FY2026
Feb 13, 2026
Q3 FY26 profit rose sequentially, preferential issue to raise ₹12.25 crore approved.
Earnings, Q2 FY2026
Nov 14, 2025
Strong revenue and profit growth with improved margins and positive operating cash flow.
Earnings, Q1 FY2026
Aug 11, 2025
Q1 FY26 saw higher revenue but lower net profit and EPS amid rising expenses.
2025
Earnings, Q4 FY2025
Annual
May 28, 2025
Revenue and net profit increased, with global expansion and capital restructuring highlighted.
Earnings, Q3 FY2025
Feb 6, 2025
Q3 FY25 revenue was flat, but net profit fell on higher costs; auditors found no misstatements.
Earnings, Q2 FY2025
Nov 14, 2024
Revenue and net profit rose year-over-year, with strong equity growth and robust financing inflows.
Earnings, Q1 FY2025
Aug 14, 2024
Q1 FY25 saw higher revenue, a return to profit, and increased share capital.
2024
Earnings, Q4 FY2024
Annual
May 30, 2024
Earnings, Q3 FY2024
Feb 2, 2024
Earnings, Q2 FY2024
Nov 8, 2023
Earnings, Q1 FY2024
Aug 7, 2023